LEUVATE supplement effects on blood sugar in GLP-1 users
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether a supplement called LEUVATE affects blood sugar, insulin, and muscle protein in adults taking GLP-1 medications (like Ozempic or Wegovy). The trial wants to understand how this supplement works alongside these popular weight-loss drugs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 30 and 65 years old
- Be on a GLP-1 RA medication (like Ozempic, Wegovy, or Mounjaro) for no more than 6 months
- Have lost 1–5 kilograms (2–11 pounds) since starting your GLP-1 medication
- Not pregnant, and not a current smoker or tobacco user
- Not allergic to dairy, and not following a vegan diet
- No history of muscle-wasting diseases, kidney/stomach problems, heart disease, or uncontrolled blood pressure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a weight-loss medication (GLP-1 receptor agonist) combined with dietary protein to see if it helps protect muscle while losing fat. It is for adults with obesity who are not taking certain other medications or supplements.
This study tests whether a daily supplement can help fill nutrient gaps and improve gut health for people who are already taking GLP-1 weight-loss medications (like Ozempic or Wegovy). Participants must be on a stable dose for at least 8 weeks and be generally healthy without other chronic conditions.
This study tests if a type 2 diabetes medication called a GLP-1 receptor agonist (like Ozempic) is safe and effective for people on dialysis. It may help manage blood sugar and improve health outcomes for those with kidney failure.
This study looks at whether exercise can help prevent muscle loss in people taking GLP-1 medications (like Wegovy, Ozempic, or Mounjaro) for weight loss. It may help you keep your muscles strong while you lose weight.
This trial tests a special medical food to help keep muscle mass while losing weight with GLP-1 medications like liraglutide, semaglutide, or tirzepatide. It's for adults with obesity or overweight with related health issues.
This study follows people who recently stopped taking a GLP-1 medication (like Wegovy or Ozempic) to understand how weight, eating habits, and daily routines change over time. It aims to help patients and doctors know what to expect after stopping the drug.
Hear when a new The Whole-body Protein Synthesis Response to Protein With Amino Acid or Amino Acids trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.